Search Within

Urvi A Shah

Formats
  1. Meeting Abstract (126)
  2. Journal Article (35)
  3. Research Letter (11)
  4. Review (9)
  5. Correspondence (3)
  6. Editorial (2)
Groups
  1. CTCR Scholars (186)
  2. Department of Medicine (186)
  3. Hematologic Malignancies, Division of (186)
  4. Center for Hematologic Malignancies (146)
  5. Myeloma (145)
  6. Hematologic Malignancies Research (140)

More Groups

People
  1. Alexander Lesokhin (136)
  2. Sham Mailankody (131)
  3. Malin Hultcrantz (125)
  4. Hani Hassoun (123)
  5. Neha Korde (123)
  6. Carlyn Rose Tan (112)

More People

Years
  1. 2025 (4)
  2. 2024 (38)
  3. 2023 (44)
  4. 2022 (44)
  5. 2021 (16)
  6. 2020 (20)

More Years

Publications
  1. Blood (66)
  2. Clinical Lymphoma, Myeloma and Leukemia (42)
  3. Journal of Clinical Oncology (15)
  4. Blood Cancer Journal (8)
  5. Blood Advances (6)
  6. Biology of Blood and Marrow Transplantation (4)

More Publications

Publishers
  1. American Society of Hematology (72)
  2. Elsevier Inc. (51)
  3. American Society of Clinical Oncology (15)
  4. Nature Publishing Group (13)
  5. American Association for Cancer Research (5)
  6. American Medical Association (4)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: A retrospective study of 34 patients highlighting the need for consensus criteria
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Jaffer-Sathick, I.; Rossi, A.; Salvatore, S.; Landau, H.; Lahoud, O.; Korde, N.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study
    Meeting Abstract

    Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Microbial changes in response to a plant-based diet and/or supplements in SMM patients: A national multi-arm randomized prospective telehealth study via HealthTree: The nutrition prevention (NUTRIVENTION-2) study
    Meeting Abstract

    Castro, F.; Sweeney, N. W.; Derkach, A.; Traore, K.; Anuraj, A.; Guttentag, L.; Blaslov, J.; Sahagun, A.; Hydren, J.; Chmielewski, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Low intake of fruits and vegetables and high intake of processed meats and juices are associated with risk of MGUS in the national health and nutrition examination survey (NHANES) database
    Meeting Abstract

    Joseph, J. M.; Tang, L.; Hillengass, J.; Moysich, K.; Landgren, O.; Usmani, S.; Lesokhin, A. M.; McCann, S. E.; Shah, U. A.
    Blood (2022)

    Fulltext@MSK | Save
  • Factors associated with early mortality in patients with multiple myeloma: A SEER analysis
    Meeting Abstract

    Wei, J. X.; Sisto, A.; Shastri, A.; Sica, R. A.; Mantzaris, I.; Kornblum, N.; Shah, U. A.; Janakiram, M.; Gritsman, K.; Verma, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Trends in collection and utilization of autologous hematopoietic stem cells (APBHC) intended for transplant in patients with multiple myeloma
    Meeting Abstract

    Samuel, N.; Laufer, L.; Tanaguchi, R.; Rosiene, J.; Palesi, C.; Elkind, R.; Mantzaris, I.; Shastri, A.; Kornblum, N.; Sica, R. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world single center experience
    Meeting Abstract

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; Maclachlan, K. H.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C.; Akhlaghi, T.; more...
    Blood (2022)

    Fulltext@MSK | Save